Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
40 participants
OBSERVATIONAL
2022-04-28
2026-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neuromuscular Mechanisms of Specific Trunk Interventions in Children With CP
NCT05805410
The Effect of Whole Body Vibration on Spasticity in Persons With Spinal Cord Injury
NCT02127606
Long-term Outcomes of Selective Dorsal Rhizotomy Among Individuals With Cerebral Palsy
NCT03789786
Spastic Myopathy in Adults With Cerebral Palsy
NCT07293988
Validation of an Obstacle Course Used in Patients With Muscle Tightness
NCT00776048
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The MAS and Tardieu function mainly on the principal of catch, a limb is moved slowly by a clinician through the available range of motion, and then quickly. Hyperactive muscles are sensitive to velocity dependent stretch and will activate a reflex if quickly perturbed. In both the MAS and Tardieu, the catch location is noted and translated into a score. In MAS the catch location is only noted in three distinct ranges; with the Tardieu Scale the catch angle is remembered by the clinician and recorded after the movement with a standard goniometer.
Here we will test a new handheld spasticity measurement tool MITSS (Modified Intelligent Tardieu Scale for Spasticity), which is essentially a 3-DOF digital goniometer, to quantify the catch angle as well as general forces at the joint.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Measurement Group
All participants will have their arm spasticity to be measured using standard clinical scales
Tardieu Scale for Spasticity
The clinician will rotate the elbow joint at various speeds while the participant sits relaxed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tardieu Scale for Spasticity
The clinician will rotate the elbow joint at various speeds while the participant sits relaxed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to provide informed consent
* History of unilateral stroke
Exclusion Criteria
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shirley Ryan AbilityLab
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zev Rymer
Director Single Motor Unit Laboratory
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Z Rymer, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Director, Single Motor Unit Laboratory
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shirley Ryan AbilityLab
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU00216437
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.